With T2D being a chronic disease with sustained high blood glucose levels and affecting around 400 million people worldwide, and with approximately 90% of T2D cases being associated with overweight or obesity, obesity presents a primary target for preventative healthcare measures and treatments
Doctors sometimes recommend ESG for patients who: cannot tolerate GLP-1 medications experienced limited weight loss from medication therapy prefer a non-surgical alternative to bariatric surgery At EndoSlim Clinic NY , specialists evaluate each patient individually before recommending a procedure
*Outcomes based on internal analyses of self-reported member data that has not been independently verified.
Integrated approach to weight management combines medication with nutritional guidance, lifestyle coaching, and support for sustainable results
The Downsides: Risks, Side Effects, and Concerns Despite the headline-making results, GLP-1 drugs are not without side effects or controversy
